LEDIKAST LEDIPASVIR AND SOFOSBUVIR TABLETS

Get a Price/Quote

LEDIKAST LEDIPASVIR AND SOFOSBUVIR TABLETS Specification

Origin of Medicine
India

Salt Composition
Ledipasvir and Sofosbuvir

Pacakaging (Quantity Per Box)
28 Tablets

Indication
For the treatment of chronic hepatitis C virus (HCV) infection

Dosage Form
Tablet

Drug Type
Allopathic

Ingredients
Ledipasvir 90 mg, Sofosbuvir 400 mg

Physical Form
Tablets

Function
Antiviral - Hepatitis C treatment

Recommended For
Chronic Hepatitis C infection

Dosage
As directed by physician

Dosage Guidelines
One tablet daily or as prescribed

Suitable For
Adults

Quantity
28 Tablets per box

Storage Instructions
Store below 30C, protect from moisture and light

Trade Mark
LEDIKAST

Therapeutic Class
Antiviral agent

Strength
Ledipasvir 90 mg + Sofosbuvir 400 mg

Prescription Required
Yes

Brand Name
Ledikast

Primary Packing
Bottle

Colour of Tablet
Yellow

Shelf Life
24 months

Route of Administration
Oral

LEDIKAST LEDIPASVIR AND SOFOSBUVIR TABLETS Trade Information

Packaging Details
PACK OF 28 TABLETS

Main Domestic Market
All India

About LEDIKAST LEDIPASVIR AND SOFOSBUVIR TABLETS

Ledikast Tablets

Specifications:-

Brand Name : LEDIKAST
Content: Ledipasvir & Sofosbuvir
Strengths: 90Mg +400Mg
Form :Tablets
Packing: Pack of 28 Tablets
Manufactured by : Aprazer

Note :-LEDIKAST Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice.Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug..............

Powerful Dual-Action Formula

Ledikast combines two potent antiviral agentsLedipasvir and Sofosbuvirto deliver a synergistic effect against hepatitis C infection. This dual-action mechanism impedes viral replication, resulting in higher rates of sustained virologic response. Its allopathic formulation is specifically tailored for adult patients battling chronic HCV, aiming to reduce viral loads effectively.

User-Friendly Dosage and Administration

This product is designed for convenient oral administration, typically one yellow tablet taken once daily, or as prescribed by a healthcare professional. The easy-to-follow regimen supports greater adherence and successful treatment outcomes. Ledikast comes in sealed bottles, with each pack containing 28 tablets, providing a full monthly course per box for patient convenience.

Assured Quality and Safe Handling

Ledikast is securely packaged in bottles to preserve tablet integrity and is manufactured according to stringent quality standards in India. For optimal efficacy, storage guidelines include keeping the medicine below 30C and shielding it from moisture and light. This helps ensure the tablets maintain potency and safety throughout their 24-month shelf life.

FAQs of LEDIKAST LEDIPASVIR AND SOFOSBUVIR TABLETS:

Q: How should Ledikast tablets be taken for maximum effectiveness?

A: Ledikast tablets should be taken orally once daily, ideally at the same time each day, with or without food. It is important to follow your physicians instructions regarding duration and timing for the best therapeutic outcome. Do not stop or alter the prescribed regimen without medical consultation.

Q: What is the main use of Ledikast and who is it recommended for?

A: Ledikast is primarily indicated for the treatment of chronic hepatitis C virus (HCV) infection in adults. It is recommended for patients diagnosed with chronic HCV as determined by their healthcare provider.

Q: When can patients expect to see benefits from taking Ledikast for hepatitis C?

A: Most patients start to see improvements within several weeks of consistent treatment, though individual responses may vary. The goal is to achieve a sustained virologic response, often evaluated after a complete course prescribed by the physician. Regular follow-up and laboratory monitoring are essential to assess effectiveness.

Q: Where should Ledikast be stored to maintain its quality?

A: Store Ledikast tablets below 30C in a cool, dry place, away from direct moisture and light. Keeping the bottle tightly closed and in its original packaging will help preserve the medicines stability and potency.

Q: What is the process for obtaining Ledikast tablets?

A: Ledikast is a prescription-only medication, meaning it requires evaluation and prescription from a licensed healthcare professional. Once prescribed, it can be obtained from pharmacies, authorized distributors, or exporters, especially those handling pharmaceutical products in India.

Q: What are the key benefits of Ledikast in treating hepatitis C?

A: Ledikast provides a comprehensive antiviral approach by combining Ledipasvir and Sofosbuvir, which work synergistically to disrupt HCV replication. This enhances treatment efficacy, improves cure rates, and typically has a manageable side effect profile compared to older HCV therapies.

Q: Is Ledikast suitable for everyone with hepatitis C infection?

A: Ledikast is recommended for adults diagnosed with chronic HCV as determined by a healthcare provider. It may not be suitable for patients with certain coexisting conditions or those taking specific medications; therefore, candidacy for Ledikast should always be assessed by a physician.

Tell us about your requirement